Hemocompatibility of Medical Connectors with Biopassive or Bioactive Surface Coatings

Abstract

Although medical connectors compose very small parts of the extracorporeal circulation (ECC) systemthey represent a critical localization where early thromboembolic processes can manifest. In the present study we modified an in vitro closed-loop model with fresh human whole blood for the preclinical evaluation of the hemocompatibility of three types of medical connectors: non-coated (control); with silicone-, and heparin-coating. Each single loop consists of five polycarbonate connectors joined together by five pieces of silicone tubes. Thrombin-antithrombin-III, β-thromboglobulin (β-TG), PMN-Elastase, terminal complement complex, CD 11b expression, and surface-absorbed fibrinogen were measured. After 1 and 2 h recirculation, platelet loss, release of β-TG, and adsorption of fibrinogen were significantly higher (p<0.05) within the non-coated connectors compared to the silicone- and heparin-coated groups. Following this experiment, the connectors were filled again with fresh heparinized whole blood from the same donor to evaluate the influence of prior blood contact. Here, the activation of platelets and coagulation was dependent on the duration of the blood preincubation period.

Probably, the coated surfaces possess a reduced, or selective adsorption of plasma proteins, which in turn leads to a faster creation of a blood-friendly secondary superficial membrane, and prevents a further denaturation and hence activation of the adsorbed proteins.

Get full access to this article

View all access options for this article.

References

1. Colman, R.W. , Scott, C.F. , Schmaier, A.H. , Wachtfogel, Y.T. , Pixley, R.A. and Edmunds, L.H. Jr. (1987). Initiation of blood coagulation at artificial surfaces. In: Leonard, E.F. , Turrito, V.T. and Vroman, L. (eds.), Ann. N.Y. Acad. Sci.,

2. Vroman, L. (1988). The life of an artificial device in contact with blood: initial events and their effect on its final state. Bull. N. Y. Acad. Med., 64: 352–357.

3. Wendel, H.P. and Ziemer, G. (1999). Coating-techniques to improve the hemocompatibility of artificial surfaces used for extracorporeal circulation. Eur. J. Cardiothorac. Surg., 16: 342–350.

4. Wan, S. , LeClerc, J.L. and Vincent, J.L. (1997). Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest, 112: 676–692.

5. Hill, G.E. (1998). Cardiopulmonary bypass-induced inflammation: is it important? J. Cardiothorac. Vasc. Anesth., 12: 21–25.

6. Gott, V.L. , Whiffen, J.D. and Dutton, R.C. (1963). Heparin bonding on colloidal graphite surfaces. Science, 142: 1297–1298.

7. Larm, O. , Larsson, R. and Olsson, P. (1983). A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater. Med. Devices Artif. Organs., 11: 161–173.

8. Bannan, S. , Danby, A. , Cowan, D. , Ashraf, S. and Martin, P.G. (1997). Low heparinization with heparin-bonded bypass circuits: is it a safe strategy? Ann. Thorac. Surg., 63: 663–668.

9. Fukutomi, M. , Kobayashi, S. , Niwaya, K. , Hamada, Y. and Kitamura, S. (1996). Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif. Organs., 20: 767–776.

10.

10. Kagisaki, K. , Masai, T. , Kadoba, K. , Sawa, Y. , Nomura, F. , Fukushima, N. , Ichikawa, H. , Ohata, T. , Suzuki, K. , Taketani, S. and Matsuda, H. (1997). Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass. Artif. Organs, 21: 836–840.

11.

11. Svenmarker, S. , Sandström, E. , Karlsson, T. , Jansson, E. , Häggmark, S. , Lindholm, R. , Appelblad, M. and Aberg, T. (1997). Clinical effects of the heparin coated surface in cardiopulmonary bypass. Eur. J. Cardiothorac. Surg., 11: 957–964.

12.

12. Belboul, A. and Al-Khaja, N. (1997). Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery. Perfusion, 12: 385–391.

13.

13. Weber, N. , Wendel, H.P. and Ziemer, G. (2000). Quality assessment of heparin-coatings by their binding capacities of coagulation and complement enzymes. J. Biomater. Appl., 15: 8–22.

14.

14. Chandler, A.B. (1958). In vitro thrombotic coagulation of blood; a method for producing a thrombus. Lab Invest, 7: 110–116.

15.

15. Tsai, C.C. , Deppisch, R.M. , Forrestal, L.J. , Ritzau, G.H. , Oram, A.D. , Göhl, H.J. and Voorhees, M.E. (1994). Surface modifying additives for improved device–blood compatibility. ASAIO J., 40: M619-M624.

16.

16. Gu, Y.J. , Boonstra, P.W. , Rijnsburger, A.A. , Haan, J. and van Oeveren, W. (1998). Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility. Ann. Thorac. Surg., 65: 1342–1347.

17.

17. Janvier, G. , Baquey, C. , Roth, C. , Benillan, N. , Belisle, S. and Hardy, J.F. (1996). Extracorporeal circulation, hemocompatibility, and biomaterials. Ann. Thorac. Surg., 62: 1926–1934.

18.

18. Hsu, L.C. (1997). Biocompatibility in cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth., 11: 376–382.

19.

19. Vroman, L. (1983). Possible relationships and interactions among events in clotting, platelet adhesion, immune surface reactions and granulocyte adhesion. J. Theor. Biol., 105: 541–543.

20.

20. Stanford, M.F. , Munoz, P.C. and Vroman, L. (1983). Platelets adhere where flow has left fibrinogen on glass. Ann. N. Y. Acad. Sci., 416: 504–512.

21.

21. Gluszko, P. , Rucinski, B. , Musial, J. , Wenger, R.K. , Schmaier, A.H. , Colman, R.W. , Edmunds, L.H., Jr. , Niewiarowski, S. (1987). Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit. Am. J. Physiol., 252: H615–21.

22.

22. Wenger, R.K. , Lukasiewicz, H. , Mikuta, B.S. , Niewiarowski, S. and Edmunds, L.H. (1989). Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., 97: 235–239.

23.

23. Anderson, A.B. , Tran, T.H. , Hamilton, M.J. , Chudzik, S.J. , Hastings, B.P. , Melchior, M.J. and Hergenrother, R.W. (1996). Platelet deposition and fibrinogen binding on surfaces coated with heparin or friction-reducing polymers. Am. J. Neuroradiol., 17: 859–863.

24.

24. Dewanjee, M.K. , Rowland, S.M. , Dewanjee, P.K. , Kapadvanjwala, M. , MacGregor, D.C. , Serafini, A.N. , Palatianos, G.M. , Georgiou, M.F. and Sfakianakis, G.N. (1990). The kinetics and quantitation of platelet deposition on control (CPC) and heparin-bonded polyurethane angio-catheter (HBPC) with indium-111 labeled platelets in a dog model. Prog. Clin. Biol. Res., 355: 39–48.